Ever since loss of survival motor neuron (SMN) protein was identified as the direct cause of
the childhood inherited neurodegenerative disorder spinal muscular atrophy, significant …

The most prevalent metabolic disorders are diabetes mellitus, obesity, dyslipidemia,
osteoporosis and metabolic syndrome, which are developed when normal metabolic …

Moreover, over the last few years the approach to treatment of patients with a high
cardiovascular risk has totally changed from treatment aimed at a specific risk factor (ie …

Individuals with chronic kidney disease are at increased risk of premature cardiovascular
disease. Among them, many with elevated low-density lipoprotein cholesterol (LDL-C) are …

In the last few decades, rapid changes in lifestyle have led to an alarming increase in the
prevalence of obesity and obesity-associated complications. Obese patients are at …

The available studies have reported the benefits of statins on all-cause and cardiovascular
mortality in chronic kidney disease (CKD) patients. However studies in end-stage renal …

Introduction The efficacy of statin treatment in chronic kidney disease (CKD) patients
remains controversial. Therefore, we performed a meta-analysis to investigate whether …

The year 2013 proved to be very exciting as far as landmark trials and new guidelines in the
field of lipid disorders, blood pressure and kidney diseases. Among these are the …

The main causes of death in patients with chronic kidney disease (CKD) are of
cardiovascular nature. The interaction between traditional cardiovascular risk factors (CVRF) …

The metabolic syndrome (MetS) is characterized by a cluster of risk factors including central
obesity, hypertension, dyslipidemia and insulin resistance, The MetS is associated with an …